| 國立成功大學 |
2023 |
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma The JUPITER-02 Randomized Clinical Trial
|
Mai, H.-Q.;Chen, Q.-Y.;Chen, D.;Hu, C.;Yang, K.;Wen, J.;Li, J.;Shi, Y.;Jin, F.;Xu, R.;Pan, J.;Qu, S.;Li, P.;Hu, C.;Liu, Y.-C.;Jiang, Y.;He, X.;Wang, H.-M.;Lim, W.-T.;Liao, W.;He, X.;Chen, X.;Wang, S.;Yuan, X.;Li, Q.;Lin, X.;Jing, S.;Chen, Y.;Lu, Y.;Hsieh, C.-Y.;Yang, M.-H.;Yen, C.-J.;Samol, J.;Luo, X.;Wang, X.;Tang, X.;Feng, H.;Yao, S.;Keegan, P.;Xu, R.-H. |
| 臺大學術典藏 |
2022-03-22T08:31:50Z |
Decision support models for annual catenary maintenance task identification and assignment
|
Xu R.-H;Lai Y.-C;Huang K.-L.; Xu R.-H; Lai Y.-C; Huang K.-L.; KWEI-LONG HUANG |
| 臺大學術典藏 |
2022-03-22T08:31:49Z |
Decision support models for annual catenary maintenance task identification and assignment
|
Xu R.-H;Lai Y.-C;Huang K.-L.; Xu R.-H; Lai Y.-C; Huang K.-L.; KWEI-LONG HUANG |
| 臺大學術典藏 |
2022-03-22T08:28:46Z |
Decision support models for annual catenary maintenance task identification and assignment
|
Xu R.-H;Lai Y.-C;Huang K.-L.; Xu R.-H; Lai Y.-C; Huang K.-L.; KWEI-LONG HUANG |
| 臺大學術典藏 |
2022-03-22T08:28:21Z |
Decision support models for annual catenary maintenance task identification and assignment
|
Xu R.-H;Lai Y.-C;Huang K.-L.; Xu R.-H; Lai Y.-C; Huang K.-L.; YUNG-CHENG LAI |
| 臺大學術典藏 |
2022-03-22T08:28:21Z |
Decision support models for annual catenary maintenance task identification and assignment
|
Xu R.-H;Lai Y.-C;Huang K.-L.; Xu R.-H; Lai Y.-C; Huang K.-L.; YUNG-CHENG LAI |
| 臺大學術典藏 |
2022-03-22T08:25:35Z |
Decision support models for annual catenary maintenance task identification and assignment
|
Xu R.-H;Lai Y.-C;Huang K.-L.; Xu R.-H; Lai Y.-C; Huang K.-L.; YUNG-CHENG LAI |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study
|
Satoh T.;Doi T.;Ohtsu A.;Tsuji A.;Omuro Y.;Mukaiyama A.;Kobayashi M.;Miwa H.;Xu R.-H.;Sun G.-P.;Xu J.-M.;Wang J.-W.;Li J.;Qin S.-K.;Feng J.-F.;Chung H.C.;Bang Y.-J.;Chung I.-J.;Kun-Huei Yeh; Satoh T.; Doi T.; Ohtsu A.; Tsuji A.; Omuro Y.; Mukaiyama A.; Kobayashi M.; Miwa H.; Xu R.-H.; Sun G.-P.; Xu J.-M.; Wang J.-W.; Li J.; Qin S.-K.; Feng J.-F.; Chung H.C.; Bang Y.-J.; Chung I.-J.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:21Z |
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: A JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
|
Yoshino T.;Arnold D.;Taniguchi H.;Pentheroudakis G.;Yamazaki K.;Xu R.-H.;Kim T.W.;Ismail F.;Tan I.B.;Kun-Huei Yeh;Grothey A.;Zhang S.;Ahn J.B.;Mastura M.Y.;Chong D.;Chen L.-T.;Kopetz S.;Eguchi-Nakajima T.;Ebi H.;Ohtsu A.;Cervantes A.;Muro K.;Tabernero J.;Minami H.;Ciardiello F.;Douillard J.-Y.; Yoshino T.; Arnold D.; Taniguchi H.; Pentheroudakis G.; Yamazaki K.; Xu R.-H.; Kim T.W.; Ismail F.; Tan I.B.; KUN-HUEI YEH; Grothey A.; Zhang S.; Ahn J.B.; Mastura M.Y.; Chong D.; Chen L.-T.; Kopetz S.; Eguchi-Nakajima T.; Ebi H.; Ohtsu A.; Cervantes A.; Muro K.; Tabernero J.; Minami H.; Ciardiello F.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
|
Xu J.; Xu R.-H.; Qin S.; Pan H.; Bai Y.; Chi Y.; Wang L.; Bi F.; Cheng Y.; Liu T.; Ma D.; Shen L.; Ba Y.; Liang J.; Wang X.; Yau T.C.C.; Ma B.B.; KUN-HUEI YEH; Lin J.-K.; Kappeler C.; Shapiro J.; Kalmus J.; Li J. |
